日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma

微生物组、表观基因组学、免疫反应和剪接特征的相互作用:调控通路组合作为恶性间皮瘤治疗靶点的潜在应用

Setlai, Botle Precious; Mkhize-Kwitshana, Zilungile Lynette; Mehrotra, Ravi; Mulaudzi, Thanyani Victor; Dlamini, Zodwa

Immunosuppressive Signaling Pathways as Targeted Cancer Therapies

免疫抑制信号通路作为靶向癌症疗法

Setlai, Botle Precious; Hull, Rodney; Bida, Meshack; Durandt, Chrisna; Mulaudzi, Thanyani Victor; Chatziioannou, Aristotelis; Dlamini, Zodwa

MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma

胶质母细胞瘤中microRNA相关的上皮间质转化(EMT)

Setlai, Botle Precious; Hull, Rodney; Reis, Rui Manuel; Agbor, Cyril; Ambele, Melvin Anyasi; Mulaudzi, Thanyani Victor; Dlamini, Zodwa

The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay

利用噬菌体展示和酵母表达系统开发血管性血友病因子前肽检测方法:血管性血友病因子前肽检测方法的开发

S M Meiring,B D P Setlai,C Theron,R Bragg